Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · IEX Real-Time Price · USD

8.03

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

8.09

+0.06 (0.75%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Orchestra BioMed Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	287	326	306	206	262
Market Cap Growth	-68.55%	6.75%	48.31%	-21.31%	-
Enterprise Value	214	240	234	201	236
PE Ratio	-	-6.64	-9.10	-8.96	-12.27
PS Ratio	129.68	118.24	86.53	-263.60	45.94
PB Ratio	5.03	4.80	5.82	-10.42	-5.40
P/FCF Ratio	-4.20	-7.06	-10.23	-10.46	-9.80
P/OCF Ratio	-4.20	-7.07	-10.44	-10.61	-10.01
EV/Sales Ratio	96.56	87.11	66.18	-256.92	41.32
EV/EBITDA Ratio	-2.31	-4.99	-7.12	-9.17	-10.93
EV/EBIT Ratio	-2.27	-4.89	-6.96	-9.10	-10.87
EV/FCF Ratio	-2.56	-5.20	-7.82	-10.20	-8.82
Debt / Equity Ratio	0.03	0.02	0.23	-0.29	-0.19
Debt / EBITDA Ratio	-0.03	-0.03	-0.36	-0.26	-0.44
Debt / FCF Ratio	-0.04	-0.04	-0.40	-0.29	-0.35
Quick Ratio	7.21	7.82	4.52	0.90	2.50
Current Ratio	7.34	7.95	4.56	0.93	2.52
Asset Turnover	0.02	0.02	0.03	-0.01	-
Interest Coverage	-57.35	-	-	-23.83	-
Return on Equity (ROE)	-70.20%	-58.30%	218.30%	675.20%	-
Return on Assets (ROA)	-49.20%	-41.50%	-25.50%	-18.40%	-
Return on Capital (ROIC)	-92.47%	-73.86%	-50.71%	154.53%	47.98%
Earnings Yield	-17.97%	-15.05%	-10.99%	-11.16%	-8.15%
FCF Yield	-15.63%	-14.16%	-9.77%	-9.56%	-10.20%
Buyback Yield / Dilution	-29.43%	-121.67%	-69.97%	-337.98%	-
Total Shareholder Return	-29.43%	-121.67%	-69.97%	-337.98%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).